New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals

Atherosclerosis

Volumn 177, Issue 2, 2004, Pages 345-351

  Judson, Richard ^a   Brain, Carlos ^a   Dain, Brad ^a   Windemuth, Andreas ^a   Ruaño, Gualberto ^b   Reed, Carol ^a  

^a Clinical Data Inc   (United States)

^b Genomas   (United States)

Author keywords

APOE; C reactive protein; Cholesterol; Hyperlipidemia

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ATORVASTATIN; C REACTIVE PROTEIN; CERIVASTATIN; PRAVASTATIN; SIMVASTATIN;

ADULT; AGED; ALLELE; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DYSLIPIDEMIA; ESTROGEN THERAPY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BODY MASS INDEX; C-REACTIVE PROTEIN; FEMALE; GENOTYPE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED;

EID: 8644247543     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.07.012     Document Type: Article

References (37)

1. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 20 2002 1557 1565
2. M. Haidari, E. Javadi, B. Sadeghi, M. Hajilooi, and J. Ghanbili Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease Clin Biochem 34 4 2001 309 315
3. J. Danesh, P. Whincup, and M. Walker Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses BMJ 321 7255 2000 199 204
4. S. de Ferranti, and N. Rifai C-reactive protein and cardiovascular disease: a review of risk prediction and interventions Clin Chim Acta 317 1/2 2002 1 15
5. T.J. Wang, B.H. Nam, and P.W. Wilson Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham heart study Arterioscler Thromb Vase Biol 22 10 2002 1662 1667
6. I. Van Der Meer, M.P. De Maat, and A.E. Hak C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the rotterdam study Stroke 33 12 2002 2750 2755
7. J. Danesh, J.G. Wheeler, and G.M. Hirschfield C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 14 2004 1387 1397
8. T.A. Pearson, G.A. Mensah, and R.W. Alexander Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 3 2003 499 511
9. K. Bach-Ngohou, H. Nazih, and F. Nazih-Sanderson Negative and independent influence of apolipoprotein E on C-reactive protein (CRP) concentration in obese adults. Potential anti-inflammatory role of apoE in vivo Intl J Obesity 25 2001 1752 1758
10. M. Manttari, V. Manninen, T. Palosuo, and C. Ehnholm Apolipoprotein E polymorphism and C-reactive protein in dyslipidemic middle-aged men Atherosclerosis 156 1 2001 237 238
11. R.A. Schwalbe, J.E. Coe, and G.L. Nelsestuen Association of rat C-reactive protein and other pentraxins with rat lipoproteins containing apolipoproteins E and Al Biochemistry 1995 10432 10439
12. A.H. Chowdhury, T. Yokoyama, and Y. Kokubo Apolipoprotein E genetic polymorphism and stroke subtypes in a Bangladeshi hospital-based study J Epidemiol 11 3 2001 131 138
13. M.J. MacLeod, R.P. De Lange, and G. Breen Lack of association between apolipoprotein E genoype and ischaemic stroke in a Scottish population Eur J Clin Invest 31 7 2001 570 573
14. J.M. Ordovas, and V. Mooser The APOE locus and the pharmacogenetics of lipid response Curr Opin Lipidol 13 2 2002 113 117
15. J.E. Eichner, S.T. Dunn, and G. Perveen Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review Am J Epidemiol 155 6 2002 487 495
16. R.Y. Zee, and P.M. Ridker Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis Atherosclerosis 162 1 2002 217 219
17. M.A. Vickers, F.R. Green, and C. Terry Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein Cardiovasc Res 53 4 2002 1029 1034
18. NIH. National Cholesterol Education Program. Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), Final Report. NIH Pub. No. 02-5215. 2002.
19. J.C. Stephens, J.A. Schneider, and D.A. Tanguay Haplotype variation and linkage disequilibrium in 313 human genes Science 293 5529 2001 489 493
20. Stephens JC, Windemuth A. Method and system for determining haplotypes from a collection of polymorphisms, Patent WO 01/80156. World Intellectual Property Organization, Geneva, Switzerland, 2001.
21. M.J. LaMonte, J.L. Durstine, and F.G. Yanowitz Cardiorespiratory fitness and C-reactive protein among a tri-ethnic sample of women Circulation 106 4 2002 403 406
22. M. Visser, L.M. Bouter, G.M. McQuillan, M.H. Wener, and T.B. Harris Elevated C-reactive protein levels in overweight and obese adults JAMA 282 22 1999 2131 2135
23. A. Tchernof, A. Nolan, C.K. Sites, P.A. Ades, and E.T. Poehlman Weight loss reduces C-reactive protein levels in obese postmenopausal women Circulation 2002 564 569
24. N.G. Forouhi, N. Sattar, and P.M. McKeigue Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians Int J Obes Relat Metab Disord 25 9 2001 1327 1331
25. L.K. Heilbronn, M. Noakes, and P.M. Clifton Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women Arterioscler Thromb Vase Biol 21 6 2001 968 970
26. L.E. Rohde, C.H. Hennekens, and P.M. Ridker Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men Am J Cardiol 84 9 1999 1018 1022
27. J.P. McConnell, E.L. Branum, and K.V. Ballman Gender differences in C-reactive protein concentrations-confirmation with two sensitive methods Clin Chem Lab Med 40 1 2002 56 59
28. X. Garcia-Moll, E. Zoundakis, D. Cole, and J.C. Kaski C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men Eur Heart J 21 19 2000 1598 1606
29. J. Danesh, J. Muir, Y.K. Wong, M. Ward, J.R. Gallimore, and M.B. Pepys Risk factors for coronary heart disease and acute-phase proteins. A population-based study Eur Heart J 20 13 1999 954 959
30. P. Primatesta, E. Falaschetti, and N.R. Poulter Influence of hormone replacement therapy on C-reactive protein: population-based data J Cardiovasc Risk 10 1 2003 57 60
31. W.G. Wood, J. Ludemann, R. Mitusch, J. Heinrich, R. Maass, and U. Frick Evaluation of a sensitive immunoluminometric assay for the determination of C-reactive protein (CRP) in serum and plasma and the establishment of reference ranges for different groups of subjects Clin Lab 46 3/4 2000 131 140
32. S. Yamada, T. Gotoh, and Y. Nakashima Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi medical school cohort study Am J Epidemiol 153 12 2001 1183 1190
33. A.R. Tall C-reactive protein reassessed N Engl J Med 350 14 2004 1450 1452
34. A. Scuteri, A.J. Bos, and A.B. Zonderman Is the apoE4 allele an independent predictor of coronary events? Am J Med 110 1 2001 28 32
35. P.W. Wilson, E.J. Schaefer, M.G. Larson, and J.M. Ordovas Apolipoprotein E alleles and risk of coronary disease. A meta-analysis Arterioscler Thromb Vase Biol 16 10 1996 1250 1255
36. Q. Chen, S.E. Reis, and C.M. Kammerer APOE polymorphism and angiographie coronary artery disease severity in the women's ischemia syndrome evaluation (WISE) study Atherosclerosis 169 1 2003 159 167
37. J.N. Hirschhorn, K. Lohmueller, E. Byrne, and K. Hirschhorn A comprehensive review of genetic association studies Genet Med 4 2 2002 45 61